Detalhe da pesquisa
1.
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial.
J Infect Dis
; 225(11): 1923-1932, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079784
2.
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.
Lancet
; 381(9871): 1021-8, 2013 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23391465
3.
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.
EClinicalMedicine
; 31: 100689, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33392485